Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity.

Michigami T, Shimizu N, Williams PJ, Niewolna M, Dallas SL, Mundy GR, Yoneda T.

Blood. 2000 Sep 1;96(5):1953-60.

2.

Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma.

Choi SJ, Cruz JC, Craig F, Chung H, Devlin RD, Roodman GD, Alsina M.

Blood. 2000 Jul 15;96(2):671-5.

3.

Introduction: the evolving role of bisphosphonate therapy in multiple myeloma.

Raje N, Anderson KC.

Blood. 2000 Jul 15;96(2):381-3. Review. No abstract available.

4.

Cellular signaling by neural cell adhesion molecules of the immunoglobulin superfamily.

Crossin KL, Krushel LA.

Dev Dyn. 2000 Jun;218(2):260-79. Review.

5.

Molecular analysis of the hematopoiesis supporting osteoblastic cell line U2-OS.

Nelissen JM, Torensma R, Pluyter M, Adema GJ, Raymakers RA, van Kooyk Y, Figdor CG.

Exp Hematol. 2000 Apr;28(4):422-32.

PMID:
10781900
6.

New insights into role of microenvironment in multiple myeloma.

Tricot G.

Lancet. 2000 Jan 22;355(9200):248-50. Review. No abstract available.

PMID:
10675068
7.

Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: a possible role for HGF in myeloma-associated osteolytic bone disease.

Hjertner O, Torgersen ML, Seidel C, Hjorth-Hansen H, Waage A, Børset M, Sundan A.

Blood. 1999 Dec 1;94(11):3883-8.

8.

Diffuse large B cell lymphoma expressing the natural killer cell marker CD56.

Sekita T, Tamaru JI, Isobe K, Harigaya K, Masuoka S, Katayama T, Kobayashi M, Mikata A.

Pathol Int. 1999 Aug;49(8):752-8.

PMID:
10504545
9.

Clinical significance of bone marrow biopsy and plasma cell morphology in MM and MGUS.

Bartl R, Frisch B.

Pathol Biol (Paris). 1999 Feb;47(2):158-68. Review.

PMID:
10192882
10.

Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.

Ocqueteau M, Orfao A, Almeida J, Bladé J, González M, García-Sanz R, López-Berges C, Moro MJ, Hernández J, Escribano L, Caballero D, Rozman M, San Miguel JF.

Am J Pathol. 1998 Jun;152(6):1655-65.

11.

Microvillous lymphomas are B-cell neoplasms that frequently express CD56.

Hammer RD, Vnencak-Jones CL, Manning SS, Glick AD, Kinney MC.

Mod Pathol. 1998 Mar;11(3):239-46.

PMID:
9521469
12.

Neural cell adhesion molecule (N-CAM) domains and intracellular signaling pathways involved in the inhibition of astrocyte proliferation.

Krushel LA, Tai MH, Cunningham BA, Edelman GM, Crossin KL.

Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2592-6.

13.

POEMS syndrome: report on six patients with unusual clinical signs, elevated levels of cytokines, macrophage involvement and chromosomal aberrations of bone marrow plasma cells.

Rose C, Zandecki M, Copin MC, Gosset P, Labalette M, Hatron PY, Jauberteau MO, Devulder B, Bauters F, Facon T.

Leukemia. 1997 Aug;11(8):1318-23.

PMID:
9264387
14.

Pathogenesis and management of bone lesions in multiple myeloma.

Bataille R, Manolagas SC, Berenson JR.

Hematol Oncol Clin North Am. 1997 Apr;11(2):349-61. Review.

PMID:
9137974
16.

Homophilic adhesion mediated by the neural cell adhesion molecule involves multiple immunoglobulin domains.

Ranheim TS, Edelman GM, Cunningham BA.

Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4071-5.

17.

Serum neural cell adhesion molecule differentiates multiple myeloma from paraproteinemias due to other causes.

Ong F, Kaiser U, Seelen PJ, Hermans J, Wijermans PW, de Kieviet W, Jaques G, Kluin-Nelemans JC.

Blood. 1996 Jan 15;87(2):712-6.

18.

Phenotypic difference of normal plasma cells from mature myeloma cells.

Harada H, Kawano MM, Huang N, Harada Y, Iwato K, Tanabe O, Tanaka H, Sakai A, Asaoku H, Kuramoto A.

Blood. 1993 May 15;81(10):2658-63.

19.

Analysis of multidrug-resistance (MDR-1) glycoprotein and CD56 expression to separate monoclonal gammopathy from multiple myeloma.

Sonneveld P, Durie BG, Lokhorst HM, Frutiger Y, Schoester M, Vela EE.

Br J Haematol. 1993 Jan;83(1):63-7.

PMID:
7679588
20.

Excessive bone resorption in human plasmacytomas: direct induction by tumour cells in vivo.

Bataille R, Chappard D, Basle M.

Br J Haematol. 1995 Jul;90(3):721-4.

PMID:
7647018

Supplemental Content

Support Center